Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity

Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The prevention of SARS-CoV-2 transmission has become a global priority. Previously, we showed that a protein subunit vaccine that was developed based on the fus...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugaraj, Balamurugan, Khorattanakulchai, Narach, Panapitakkul, Chalisa, Malla, Ashwini, Im-erbsin, Rawiwan, Inthawong, Manutsanun, Sunyakumthorn, Piyanate, Hunsawong, Taweewun, Klungthong, Chonticha, Reed, Matthew C., Kemthong, Taratorn, Suttisan, Nutchanat, Malaivijitnond, Suchinda, Srimangkornkaew, Passaraporn, Klinkhamhom, Aekkarin, Manopwisedjaroen, Suwimon, Thitithanyanont, Arunee, Taychakhoonavudh, Suthira, Phoolcharoen, Waranyoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167921/
https://www.ncbi.nlm.nih.gov/pubmed/35697573
http://dx.doi.org/10.1016/j.vaccine.2022.05.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167921/
https://www.ncbi.nlm.nih.gov/pubmed/35697573
http://dx.doi.org/10.1016/j.vaccine.2022.05.087

Ejemplares similares